Archive \ Volume.17 2026 Issue 2

Representing the Why, When, and Source of Medication Advice in a Pharmacy Knowledge Graph

, , ,
  1. Department of Pharmacy Knowledge Graphs and Reasoning, Faculty of Pharmacy, National University of Colombia, Bogota, Colombia.
  2. Department of Medication Advice Representation, Faculty of Pharmacy, University of Chile, Santiago, Chile.
  3. Department of AI Provenance and Pharmacy Knowledge, Faculty of Pharmacy, University of Antioquia, Medellin, Colombia.

Abstract

Medication advice is often represented digitally as an isolated recommendation, alert, or relation between a medicine and an action. Such representations may omit why the advice exists, when it applies, which patient or setting qualifies it, and which source or evidence supports it. This article proposes an assertion-centred pharmacy knowledge-graph architecture for representing medication advice as a context-bearing, temporally bounded, provenance-linked knowledge object. The central construct, the Medication Advice Assertion, connects medication identity, action, rationale, intended clinical goal, applicability conditions, temporal scope, source version, evidence item, evidence-strength assessment, contradiction state, responsible agent, and intended-use boundary. The architecture separates extracted associations from normative advice, evidence strength from model confidence, provenance from truth, and technical performance from clinical usefulness. It also proposes qualified relations among assertions, including support, refinement, exception, contradiction, and supersession, so that disagreement is preserved rather than silently overwritten. Evaluation is organized as a sequence of semantic-conformance, identity-resolution, provenance, temporal, applicability, contradiction, technical, workflow, safety, equity, and governance checks. Clinical use would additionally require pharmacist and stakeholder assessment, external validation, human-factors testing, monitoring, and controlled maintenance. The proposed architecture does not establish the correctness of any medication recommendation, clinical benefit, regulatory acceptance, or deployment readiness. Its original contribution is a representational and governance framework for making the why, when, and source of medication advice independently inspectable while preserving professional authority and uncertainty.


Downloads: 25
Views: 87

How to cite:
Vancouver
Alvarez M, Herrera S, Cruz D, Castro A. Representing the Why, When, and Source of Medication Advice in a Pharmacy Knowledge Graph. Arch Pharm Pract. 2026;17(2):13-20. https://doi.org/10.51847/v5Z0LHHaFi
APA
Alvarez, M., Herrera, S., Cruz, D., & Castro, A. (2026). Representing the Why, When, and Source of Medication Advice in a Pharmacy Knowledge Graph. Archives of Pharmacy Practice, 17(2), 13-20. https://doi.org/10.51847/v5Z0LHHaFi

Download Citation
References
  1. Nicholson DN, Greene CS. Constructing knowledge graphs and their biomedical applications. Comput Struct Biotechnol J. 2020;18:1414-28. doi:10.1016/j.csbj.2020.05.017
  2. Rotmensch M, Halpern Y, Tlimat A, Horng S, Sontag D. Learning a health knowledge graph from electronic medical records. Sci Rep. 2017;7(1):5994. doi:10.1038/s41598-017-05778-z
  3. Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46(D1). doi:10.1093/nar/gkx1037
  4. Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: Benefits, risks, and strategies for success. NPJ Digit Med. 2020;3:17. doi:10.1038/s41746-020-0221-y
  5. Hogan A, Blomqvist E, Cochez M, d’Amato C, de Melo G, Gutierrez C, et al. Knowledge graphs. ACM Comput Surv. 2021;54(4):71. doi:10.1145/3447772
  6. Ji S, Pan S, Cambria E, Marttinen P, Yu PS. A survey on knowledge graphs: Representation, acquisition, and applications. IEEE Trans Neural Netw Learn Syst. 2022;33(2):494-514. doi:10.1109/TNNLS.2021.3070843
  7. Herschel M, Diestelkämper R, Ben Lahmar H. A survey on provenance: What for? What form? What from? VLDB J. 2017;26(6):881-906. doi:10.1007/s00778-017-0486-1
  8. Wong D, Peek N. Does not compute: Challenges and solutions in managing computable biomedical knowledge. BMJ Health Care Inform. 2020;27(2). doi:10.1136/bmjhci-2019-100123
  9. Himmelstein DS, Lizee A, Hessler C, Brueggeman L, Chen SL, Hadley D, et al. Systematic integration of biomedical knowledge prioritizes drugs for repurposing. Elife. 2017;6. doi:10.7554/eLife.26726
  10. Piñero J, Ramírez-Anguita JM, Saüch-Pitarch J, Ronzano F, Centeno E, Sanz F, et al. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. 2020;48(D1). doi:10.1093/nar/gkz1021
  11. Zitnik M, Agrawal M, Leskovec J. Modeling polypharmacy side effects with graph convolutional networks. Bioinformatics. 2018;34(13). doi:10.1093/bioinformatics/bty294
  12. Bean DM, Wu H, Iqbal E, Dzahini O, Ibrahim ZM, Broadbent M, et al. Knowledge graph prediction of unknown adverse drug reactions and validation in electronic health records. Sci Rep. 2017;7(1):16416. doi:10.1038/s41598-017-16674-x
  13. Callahan TJ, Tripodi IJ, Pielke-Lombardo H, Hunter LE. Knowledge-based biomedical data science. Annu Rev Biomed Data Sci. 2020;3:23-41. doi:10.1146/annurev-biodatasci-010820-091627
  14. Alfattni G, Peek N, Nenadic G. Extraction of temporal relations from clinical free text: A systematic review of current approaches. J Biomed Inform. 2020;108:103488. doi:10.1016/j.jbi.2020.103488
  15. Lichtner G, Alper BS, Jurth C, Spies C, Boeker M, Meerpohl JJ, et al. Representation of evidence-based clinical practice guideline recommendations on FHIR. J Biomed Inform. 2023;139:104305. doi:10.1016/j.jbi.2023.104305
  16. Taneja SB, Callahan TJ, Paine MF, Kane-Gill SL, Kilicoglu H, Joachimiak MP, et al. Developing a knowledge graph for pharmacokinetic natural product-drug interactions. J Biomed Inform. 2023;140:104341. doi:10.1016/j.jbi.2023.104341
  17. Callahan TJ, Tripodi IJ, Stefanski AL, Cappelletti L, Taneja SB, Wyrwa JM, et al. An open source knowledge graph ecosystem for the life sciences. Sci Data. 2024;11(1):363. doi:10.1038/s41597-024-03171-w
  18. Sansone SA, McQuilton P, Rocca-Serra P, Gonzalez-Beltran A, Izzo M, Lister AL, et al. FAIRsharing as a community approach to standards, repositories and policies. Nat Biotechnol. 2019;37(4):358-67. doi:10.1038/s41587-019-0080-8
  19. Brignardello-Petersen R, Bonner A, Alexander PE, Siemieniuk RA, Furukawa TA, Rochwerg B, et al. Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis. J Clin Epidemiol. 2018;93:36-44. doi:10.1016/j.jclinepi.2017.10.005
  20. Sosa DN, Altman RB. Contexts and contradictions: A roadmap for computational drug repurposing with knowledge inference. Brief Bioinform. 2022;23(4). doi:10.1093/bib/bbac268
  21. Rossi A, Firmani D, Matinata A, Merialdo P, Barbosa D. Knowledge graph embedding for link prediction: A comparative analysis. ACM Trans Knowl Discov Data. 2021;15(2):14. doi:10.1145/3424672
  22. Ali M, Berrendorf M, Hoyt CT, Vermue L, Galkin M, Sharifzadeh S, et al. Bringing light into the dark: A large-scale evaluation of knowledge graph embedding models under a unified framework. IEEE Trans Pattern Anal Mach Intell. 2022;44(12):8825-45. doi:10.1109/TPAMI.2021.3124805
  23. Vasey B, Nagendran M, Campbell B, Clifton DA, Collins GS, Denaxas S, et al. Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI. Nat Med. 2022;28(5):924-33. doi:10.1038/s41591-022-01772-9
  24. Wiens J, Saria S, Sendak M, Ghassemi M, Liu VX, Doshi-Velez F, et al. Do no harm: A roadmap for responsible machine learning for health care. Nat Med. 2019;25(9):1337-40. doi:10.1038/s41591-019-0548-6
  25. Vollmer S, Mateen BA, Bohner G, Király FJ, Ghani R, Jonsson P, et al. Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness. BMJ. 2020;368. doi:10.1136/bmj.l6927
  26. Lekadir K, Frangi AF, Porras AR, Glocker B, Cintas C, Langlotz CP, et al. FUTURE-AI: International consensus guideline for trustworthy and deployable artificial intelligence in healthcare. BMJ. 2025;388. doi:10.1136/bmj-2024-081554
  27. Gianfrancesco MA, Tamang S, Yazdany J, Schmajuk G. Potential biases in machine learning algorithms using electronic health record data. JAMA Intern Med. 2018;178(11):1544-7. doi:10.1001/jamainternmed.2018.3763
  28. Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science. 2019;366(6464):447-53. doi:10.1126/science.aax2342
  29. Kelly CJ, Karthikesalingam A, Suleyman M, Corrado G, King D. Key challenges for delivering clinical impact with artificial intelligence. BMC Med. 2019;17(1):195. doi:10.1186/s12916-019-1426-2

 

 


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.